Pierre Berthelot

619 total citations
10 papers, 447 citations indexed

About

Pierre Berthelot is a scholar working on Epidemiology, Hepatology and Clinical Biochemistry. According to data from OpenAlex, Pierre Berthelot has authored 10 papers receiving a total of 447 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 6 papers in Hepatology and 2 papers in Clinical Biochemistry. Recurrent topics in Pierre Berthelot's work include Hepatitis B Virus Studies (6 papers), Liver Disease Diagnosis and Treatment (6 papers) and Hepatitis C virus research (5 papers). Pierre Berthelot is often cited by papers focused on Hepatitis B Virus Studies (6 papers), Liver Disease Diagnosis and Treatment (6 papers) and Hepatitis C virus research (5 papers). Pierre Berthelot collaborates with scholars based in France and Italy. Pierre Berthelot's co-authors include Françoise Carnot, Stanislas Pol, Richard J. Kahnoski, Isabelle Desportes, Paul Amouyal, Stanislas Pol, Christian Bréchot, Bertrand Nalpas, Patrice Couzigou and Marc Bourlière and has published in prestigious journals such as New England Journal of Medicine, Gastroenterology and Hepatology.

In The Last Decade

Pierre Berthelot

10 papers receiving 424 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pierre Berthelot France 9 272 250 98 60 49 10 447
Stanislas Pol France 7 488 1.8× 436 1.7× 75 0.8× 107 1.8× 49 1.0× 7 645
L. Jeffers United States 11 235 0.9× 218 0.9× 83 0.8× 69 1.1× 50 1.0× 24 511
Luiz Caetano da Silva Brazil 12 264 1.0× 326 1.3× 101 1.0× 58 1.0× 65 1.3× 33 424
Serap Arslan Türkiye 11 84 0.3× 104 0.4× 37 0.4× 43 0.7× 165 3.4× 30 403
Nicole Simon France 10 406 1.5× 440 1.8× 35 0.4× 106 1.8× 16 0.3× 12 577
A. Sebastiani Italy 11 64 0.2× 64 0.3× 91 0.9× 54 0.9× 66 1.3× 22 283
M Toti Italy 12 404 1.5× 378 1.5× 13 0.1× 74 1.2× 13 0.3× 26 566
M. Raptopoulou‐Gigi Greece 12 582 2.1× 521 2.1× 15 0.2× 25 0.4× 31 0.6× 37 704
Tatsuji Maeshiro Japan 11 555 2.0× 491 2.0× 16 0.2× 52 0.9× 38 0.8× 29 666
C. Cazorla France 7 106 0.4× 127 0.5× 46 0.5× 81 1.4× 34 0.7× 9 278

Countries citing papers authored by Pierre Berthelot

Since Specialization
Citations

This map shows the geographic impact of Pierre Berthelot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Berthelot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Berthelot more than expected).

Fields of papers citing papers by Pierre Berthelot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Berthelot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Berthelot. The network helps show where Pierre Berthelot may publish in the future.

Co-authorship network of co-authors of Pierre Berthelot

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre Berthelot. A scholar is included among the top collaborators of Pierre Berthelot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre Berthelot. Pierre Berthelot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Nalpas, Bertrand, Marc Bourlière, Patrice Couzigou, et al.. (2000). Combination of ribavirin and interferon-alfa surpasses high doses of interferon-alfa alone in patients with genotype-1b-related chronic hepatitis C. Hepatology. 31(6). 1338–1344. 47 indexed citations
2.
Couzigou, Patrice, Marc Bourlière, Armand Abergel, et al.. (1999). A randomized trial of ribavirin and interferon-α vs. interferon-α alone in patients with chronic hepatitis C who were non-responders to a previous treatment. Journal of Hepatology. 31(1). 1–7. 70 indexed citations
3.
Pol, Stanislas, Valérie Thiers, Françoise Carnot, et al.. (1995). Efficacy and tolerance of α-2b interferon therapy on HCV infection of hemodialyzed patients. Kidney International. 47(5). 1412–1418. 86 indexed citations
4.
Pol, Stanislas, Richard J. Kahnoski, Paul Amouyal, et al.. (1993). Microsporidia Infection in Patients with the Human Immunodeficiency Virus and Unexplained Cholangitis. New England Journal of Medicine. 328(2). 95–99. 132 indexed citations
5.
Nalpas, Bertrand, et al.. (1993). Secondary Immune Response to Hepatitis B Virus Vaccine in Alcoholics. Alcoholism Clinical and Experimental Research. 17(2). 295–298. 19 indexed citations
6.
Pol, Stanislas, Richard J. Kahnoski, Françoise Carnot, et al.. (1992). Enterocytozoon bieneusi infection in acquired immunodeficiency syndrome-related sclerosing cholangitis. Gastroenterology. 102(5). 1778–1781. 41 indexed citations
7.
Nalpas, Bertrand, Christine Pourcel, Gérard Feldmann, et al.. (1992). Chronic alcohol intoxication decreases the serum level of hepatitis B surface antigen in transgenic mice. Journal of Hepatology. 15(1-2). 118–124. 17 indexed citations
8.
Nalpas, Bertrand, J.-C. Trinchet, D Hartmann, et al.. (1989). Liver collagen mRNA and serum amino-terminal peptide of type III procollagen (PIIINP) levels in patients with alcoholic liver disease. Journal of Hepatology. 9(3). 351–358. 2 indexed citations
9.
Pol, Stanislas, Philippe Roingeard, Chantal Housset, et al.. (1989). Hepatitis delta virus infection in French male HBsAg-positive homosexuals. Hepatology. 10(3). 342–345. 14 indexed citations
10.
Pol, Stanislas, André Pawlak, Bertrand Nalpas, et al.. (1988). Nucleotide sequence and tissue distribution of the human mitochondrial aspartate aminotransferase mRNA. Biochemical and Biophysical Research Communications. 157(3). 1309–1315. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026